Organogenesis Holdings Management
Management criteria checks 3/4
Organogenesis Holdings' CEO is Gary Gillheeney, appointed in Jan 2014, has a tenure of 10.33 years. total yearly compensation is $6.24M, comprised of 14.6% salary and 85.4% bonuses, including company stock and options. directly owns 0.63% of the company’s shares, worth €2.15M. The average tenure of the management team and the board of directors is 6.7 years and 3.5 years respectively.
Key information
Gary Gillheeney
Chief executive officer
US$6.2m
Total compensation
| CEO salary percentage | 14.6% |
| CEO tenure | 10.3yrs |
| CEO ownership | 0.6% |
| Management average tenure | 6.7yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$6m |
| Dec 31 2023 | US$6m | US$909k | US$5m |
| Sep 30 2023 | n/a | n/a | US$13m |
| Jun 30 2023 | n/a | n/a | US$10m |
| Mar 31 2023 | n/a | n/a | US$13m |
| Dec 31 2022 | US$6m | US$883k | US$16m |
| Sep 30 2022 | n/a | n/a | US$59m |
| Jun 30 2022 | n/a | n/a | US$71m |
| Mar 31 2022 | n/a | n/a | US$83m |
| Dec 31 2021 | US$4m | US$835k | US$94m |
| Sep 30 2021 | n/a | n/a | US$62m |
| Jun 30 2021 | n/a | n/a | US$69m |
| Mar 31 2021 | n/a | n/a | US$43m |
| Dec 31 2020 | US$3m | US$823k | US$17m |
| Sep 30 2020 | n/a | n/a | -US$5m |
| Jun 30 2020 | n/a | n/a | -US$37m |
| Mar 31 2020 | n/a | n/a | -US$42m |
| Dec 31 2019 | US$1m | US$819k | -US$39m |
| Sep 30 2019 | n/a | n/a | -US$46m |
| Jun 30 2019 | n/a | n/a | -US$48m |
| Mar 31 2019 | n/a | n/a | -US$58m |
| Dec 31 2018 | US$3m | US$798k | -US$65m |
| Sep 30 2018 | n/a | n/a | -US$60m |
| Jun 30 2018 | n/a | n/a | -US$52m |
| Mar 31 2018 | n/a | n/a | -US$32m |
| Dec 31 2017 | US$1m | US$780k | -US$9m |
Compensation vs Market: Gary's total compensation ($USD6.24M) is above average for companies of similar size in the German market ($USD1.07M).
Compensation vs Earnings: Gary's compensation has been consistent with company performance over the past year.
CEO
Gary Gillheeney (68 yo)
10.3yrs
Tenure
US$6,244,671
Compensation
Mr. Gary S. Gillheeney, Sr. has been the Chief Executive Officer and President of Organogenesis Holdings Inc. since 2014 and has been its Director since December 10, 2018 & serves as its Chair of the Board...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 10.3yrs | US$6.24m | 0.63% $ 2.2m | |
| Chief Financial Officer | 3.3yrs | US$1.63m | 0.048% $ 163.2k | |
| Chief Operating Officer | 6.7yrs | US$2.16m | 0.26% $ 887.0k | |
| Chief Administrative & Legal Officer | 7.3yrs | US$1.99m | 0.063% $ 214.5k | |
| Chief Commercial Officer | 6.7yrs | US$1.92m | 0.078% $ 265.3k | |
| Secretary | no data | no data | no data | |
| Vice President of Strategy | 3.3yrs | no data | no data |
6.7yrs
Average Tenure
56.5yo
Average Age
Experienced Management: 2PQ's management team is seasoned and experienced (6.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.4yrs | US$6.24m | 0.63% $ 2.2m | |
| Director | 21.3yrs | no data | 11.29% $ 38.2m | |
| Director | 21.3yrs | no data | 11.5% $ 39.0m | |
| Lead Independent Director | 5.4yrs | US$291.46k | 0.10% $ 349.1k | |
| Director | 3.5yrs | no data | no data | |
| Independent Director | 3yrs | US$265.00k | 0.068% $ 229.6k | |
| Independent Director | 2yrs | US$226.98k | 0.068% $ 229.1k | |
| Independent Director | 2.5yrs | US$240.00k | 0.071% $ 239.9k | |
| Director | 3.5yrs | no data | no data | |
| Independent Director | 2.3yrs | US$230.52k | no data | |
| Independent Director | 2yrs | US$226.98k | 0.068% $ 229.1k |
3.5yrs
Average Tenure
58yo
Average Age
Experienced Board: 2PQ's board of directors are considered experienced (3.5 years average tenure).